Spravato Insurance Coverage in Florida in 2026

For Floridians considering Spravato (esketamine) for treatment-resistant depression, one of the most pressing practical questions is: will insurance pay for it? The answer in 2026 depends on your specific plan, your clinical history, and how well you and your provider document medical necessity. This post breaks down the current coverage landscape across Florida Medicaid and major commercial insurers.

Why Coverage Matters More for Spravato Than IV Ketamine

Spravato occupies a unique position in the ketamine treatment landscape. As the only FDA-approved form of ketamine-derived therapy for treatment-resistant depression (ICD-10: F33.2) and for major depressive disorder with acute suicidal ideation (ICD-10: F32.9), it has a defined reimbursement pathway that IV ketamine does not. IV ketamine infusions remain off-label and are almost never covered by insurance. Spravato, by contrast, is a legitimate insurance claim — which means the prior authorization process matters.

The FDA’s REMS program for Spravato requires that each dose be self-administered under clinical supervision, with patients observed for at least two hours afterward. This adds a monitoring fee on top of the drug cost. Understanding how your insurer handles both the drug and the administration is essential before you start treatment.

Florida Medicaid: Statewide Medicaid Managed Care Coverage

Florida’s Medicaid program operates primarily through the Statewide Medicaid Managed Care (SMMC) program, which contracts with private managed care organizations to deliver benefits. As of 2026, Spravato is covered under Florida Medicaid for enrollees who meet clinical criteria, but the specifics — including prior authorization requirements and step therapy obligations — vary by managed care plan.

Common managed care plans within Florida’s SMMC include Humana Medical Plan of Florida, Molina Healthcare of Florida, Simply Healthcare (Anthem), Sunshine Health (Centene), and others. Each plan has its own formulary and medical policies.

To obtain Spravato coverage through Florida Medicaid:

1. Confirm your plan’s formulary — contact your managed care plan directly or check the member portal to verify Spravato is covered under your specific plan
2. Document step therapy compliance — most Florida Medicaid plans require evidence that you have tried and failed at least two antidepressant medications; your prescribing clinician will need to document this in their prior authorization request
3. Submit a prior authorization request — your provider submits clinical documentation including diagnosis codes (typically F33.2), prior medication trials, and a Letter of Medical Necessity
4. Know your appeal rights — if the plan denies the request, you have the right to appeal; Florida Medicaid enrollees can also request a fair hearing through the Agency for Health Care Administration (AHCA)

For current Florida Medicaid policy information, the Centers for Medicare and Medicaid Services publishes state plan documents and waiver details.

Florida Blue and Other Commercial Insurers

Florida Blue (Blue Cross Blue Shield of Florida) is the largest commercial insurer in the state. Florida Blue has a medical policy for Spravato that covers it for members who meet the FDA-approved indications. Key requirements typically include:

• A diagnosis of treatment-resistant depression, defined as inadequate response to at least two adequate antidepressant trials of sufficient dose and duration
• Prescription by or in consultation with a psychiatrist or other qualified mental health professional
• Administration at a REMS-certified healthcare setting
• Prior authorization approval before the first dose

Florida Blue members should call the member services number on their insurance card and ask specifically about Spravato (esketamine, JCODE J3490 or specific HCPCS codes) and whether their specific plan includes it. Not all Florida Blue plan types — HMO, PPO, individual marketplace, employer-sponsored — have identical coverage rules.

Other significant commercial payers in Florida include:

• Aetna Florida — Aetna has a national medical policy for Spravato; Florida members should confirm their specific plan’s requirements
• UnitedHealthcare of Florida — UHC covers Spravato subject to prior authorization and step therapy documentation
• Cigna Florida — similar prior authorization and clinical criteria requirements apply
• Molina Healthcare of Florida — covers both Medicaid and marketplace plans in Florida with plan-specific prior auth criteria

Navigating Prior Authorization: A Step-by-Step Overview

Prior authorization for Spravato is one of the more involved processes in mental health coverage. Here is a practical sequence:

Step 1 — Get the psychiatric evaluation. Your provider should document your diagnosis with appropriate ICD-10 codes (F33.2 for treatment-resistant depression, F32.9 for major depressive episode, or F41.1 for generalized anxiety disorder where applicable), prior medication history, and current severity.

Step 2 — Gather medication history. The prior auth form will ask for names, doses, duration, and outcomes of previous antidepressant trials. Have your pharmacy records or prior medical records ready.

Step 3 — Submit through the right channel. Most Florida insurers accept prior auth submissions through their provider portals; your clinic’s billing department will typically handle this. Ask your clinic whether they have prior auth staff experienced with Spravato.

Step 4 — Request a peer-to-peer if denied. A peer-to-peer review allows your clinician to speak directly with the insurer’s medical director. This step alone can reverse many initial denials.

Step 5 — File a formal appeal if needed. Keep copies of all correspondence. Florida’s Insurance Code gives you the right to an internal appeal and, if that fails, an external independent review.

What Patients Should Know About Cost-Sharing

Even when Spravato is covered, patients typically face cost-sharing obligations — copays, coinsurance, or deductible amounts. Janssen, the manufacturer, has offered a patient assistance program for eligible patients who meet income criteria. Ask your provider’s billing team about manufacturer support programs.

For patients whose insurance denies coverage entirely, the out-of-pocket cost of Spravato is significant. In those cases, some providers will offer IV ketamine as a lower-cost alternative, though that treatment carries no insurance coverage of its own.

Contact our directory team for help finding a Florida provider experienced with insurance.

---

This content is for educational purposes only and does not constitute medical advice. Consult a licensed clinician about your specific situation.

Drafted by AI and reviewed by our editorial team. Last updated 2026-05-30.